Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
41
CVS Quote, Financials, Valuation and Earnings
Last price:
$80.04
Seasonality move
:
7.81%
Day range:
$79.32 - $79.85
52-week range:
$43.72 - $85.15
Dividend yield:
3.35%
P/E ratio:
207.42x
P/S ratio:
0.26x
P/B ratio:
1.38x
Volume:
3.1M
Avg. volume:
6.8M
1-year change:
76.79%
Market cap:
$100.7B
Revenue:
$372.7B
EPS (TTM):
$0.38
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $268.7B | $291.9B | $322.8B | $358.3B | $372.7B | |
| Revenue Growth (YoY) | 4.71% | 8.67% | 10.57% | 10.99% | 4.03% | |
| Cost of Revenues | $219.7B | $240.1B | $268B | $303.3B | $321.4B | |
| Gross Profit | $49B | $51.9B | $54.8B | $54.9B | $51.3B | |
| Gross Profit Margin | 18.24% | 17.77% | 16.98% | 15.33% | 13.76% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $35.1B | $37.1B | $38.2B | $39.8B | $41.6B | |
| Other Inc / (Exp) | -$1.2B | -$2.1B | -$8.2B | -$768M | -$689M | |
| Operating Expenses | $35.1B | $36.9B | $38.2B | $39.3B | $41.4B | |
| Operating Income | $13.9B | $14.9B | $16.6B | $15.6B | $9.9B | |
| Net Interest Expenses | $2.9B | $2.5B | $2.3B | $2.6B | $2.9B | |
| EBT. Incl. Unusual Items | $9.8B | $10.4B | $5.8B | $11.2B | $6.1B | |
| Earnings of Discontinued Ops. | -$9M | -- | -- | -- | -- | |
| Income Tax Expense | $2.6B | $2.5B | $1.5B | $2.8B | $1.6B | |
| Net Income to Company | $7.2B | $7.9B | $4.3B | $8.4B | $4.6B | |
| Minority Interest in Earnings | $13M | -$12M | $16M | $24M | -$28M | |
| Net Income to Common Excl Extra Items | $7.2B | $7.9B | $4.3B | $8.4B | $4.6B | |
| Basic EPS (Cont. Ops) | $5.48 | $6.00 | $3.29 | $6.49 | $3.66 | |
| Diluted EPS (Cont. Ops) | $5.46 | $5.95 | $3.26 | $6.47 | $3.66 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $18.4B | $19.5B | $20.8B | $19.9B | $14.5B | |
| EBIT | $13.9B | $14.9B | $16.6B | $15.6B | $9.9B | |
| Revenue (Reported) | $268.7B | $291.9B | $322.8B | $358.3B | $372.7B | |
| Operating Income (Reported) | $13.9B | $14.9B | $16.6B | $15.6B | $9.9B | |
| Operating Income (Adjusted) | $13.9B | $14.9B | $16.6B | $15.6B | $9.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $73.8B | $81.3B | $89.9B | $95.4B | $102.9B | |
| Revenue Growth (YoY) | 10.1% | 10.1% | 10.63% | 6.12% | 7.83% | |
| Cost of Revenues | $61.1B | $67.8B | $76.2B | $82.9B | $89.1B | |
| Gross Profit | $12.7B | $13.5B | $13.7B | $12.5B | $13.8B | |
| Gross Profit Margin | 17.24% | 16.62% | 15.26% | 13.14% | 13.43% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.2B | $9.6B | $9.9B | $10.6B | $11.3B | |
| Other Inc / (Exp) | -$745M | -$7.7B | $11M | -$1.1B | -- | |
| Operating Expenses | $9.2B | $9.6B | $9.8B | $10.5B | $10.9B | |
| Operating Income | $3.5B | $3.9B | $3.9B | $2B | $3B | |
| Net Interest Expenses | $582M | $564M | $688M | $746M | $767M | |
| EBT. Incl. Unusual Items | $2.1B | -$4.4B | $3B | $105M | -$3.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $558M | -$1B | $754M | $34M | $508M | |
| Net Income to Company | $1.6B | -$3.4B | $2.3B | $71M | -$4B | |
| Minority Interest in Earnings | -$11M | $7M | $4M | -$16M | -$15M | |
| Net Income to Common Excl Extra Items | $1.6B | -$3.4B | $2.3B | $71M | -$4B | |
| Basic EPS (Cont. Ops) | $1.21 | -$2.59 | $1.76 | $0.07 | -$3.13 | |
| Diluted EPS (Cont. Ops) | $1.20 | -$2.59 | $1.75 | $0.07 | -$3.13 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $4.7B | $4.9B | $5.1B | $3.2B | $4.1B | |
| EBIT | $3.5B | $3.9B | $3.9B | $2B | $3B | |
| Revenue (Reported) | $73.8B | $81.3B | $89.9B | $95.4B | $102.9B | |
| Operating Income (Reported) | $3.5B | $3.9B | $3.9B | $2B | $3B | |
| Operating Income (Adjusted) | $3.5B | $3.9B | $3.9B | $2B | $3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $285B | $315.3B | $348.2B | $369.2B | $393.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $234.7B | $260.9B | $293.4B | $316.5B | $339.4B | |
| Gross Profit | $50.3B | $54.4B | $54.8B | $52.6B | $54.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $36.4B | $38.2B | $39.4B | $41.7B | $44B | |
| Other Inc / (Exp) | -$1.3B | -$9.5B | -$858M | -$1.1B | -- | |
| Operating Expenses | $36.2B | $38.2B | $39.1B | $41.2B | $42B | |
| Operating Income | $14.1B | $16.2B | $15.7B | $11.4B | $12.6B | |
| Net Interest Expenses | $2.5B | $2.3B | $2.5B | $2.9B | $3.1B | |
| EBT. Incl. Unusual Items | $10.1B | $4.3B | $11.6B | $6.7B | $2.9B | |
| Earnings of Discontinued Ops. | -$9M | -- | -- | -- | -- | |
| Income Tax Expense | $2.5B | $965M | $3B | $1.7B | $2.5B | |
| Net Income to Company | $7.6B | $3.3B | $8.7B | $5B | $428M | |
| Minority Interest in Earnings | -- | $8M | $21M | -$6M | -$41M | |
| Net Income to Common Excl Extra Items | $7.6B | $3.3B | $8.7B | $5B | $428M | |
| Basic EPS (Cont. Ops) | $5.75 | $2.50 | $6.69 | $3.95 | $0.39 | |
| Diluted EPS (Cont. Ops) | $5.72 | $2.46 | $6.65 | $3.94 | $0.38 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $18.7B | $20.5B | $19.9B | $16B | $17.2B | |
| EBIT | $14.1B | $16.2B | $15.7B | $11.4B | $12.6B | |
| Revenue (Reported) | $285B | $315.3B | $348.2B | $369.2B | $393.9B | |
| Operating Income (Reported) | $14.1B | $16.2B | $15.7B | $11.4B | $12.6B | |
| Operating Income (Adjusted) | $14.1B | $16.2B | $15.7B | $11.4B | $12.6B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $215.5B | $238.8B | $264.3B | $275.2B | $296.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $177.1B | $198B | $223.4B | $236.6B | $254.6B | |
| Gross Profit | $38.4B | $40.9B | $40.9B | $38.6B | $41.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $27B | $28.1B | $29.3B | $31.2B | $33.5B | |
| Other Inc / (Exp) | -$650M | -$8.1B | -$790M | -$1.1B | $57M | |
| Operating Expenses | $26.9B | $28.1B | $29B | $30.9B | $31.5B | |
| Operating Income | $11.5B | $12.7B | $11.9B | $7.7B | $10.3B | |
| Net Interest Expenses | $1.9B | $1.7B | $2B | $2.2B | $2.3B | |
| EBT. Incl. Unusual Items | $8.9B | $2.7B | $8.5B | $4B | $782M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2B | $691M | $2.1B | $1.1B | $2B | |
| Net Income to Company | $6.6B | $2B | $6.3B | $3B | -$1.2B | |
| Minority Interest in Earnings | -$2M | $18M | $23M | -$7M | -$20M | |
| Net Income to Common Excl Extra Items | $6.6B | $2B | $6.3B | $3B | -$1.2B | |
| Basic EPS (Cont. Ops) | $5.01 | $1.51 | $4.90 | $2.36 | -$0.92 | |
| Diluted EPS (Cont. Ops) | $4.98 | $1.48 | $4.88 | $2.35 | -$0.92 | |
| Weighted Average Basic Share | $4B | $3.9B | $3.9B | $3.8B | $3.8B | |
| Weighted Average Diluted Share | $4B | $4B | $3.9B | $3.8B | $3.8B | |
| EBITDA | $14.9B | $15.9B | $15.1B | $11.2B | $13.8B | |
| EBIT | $11.5B | $12.7B | $11.9B | $7.7B | $10.3B | |
| Revenue (Reported) | $215.5B | $238.8B | $264.3B | $275.2B | $296.4B | |
| Operating Income (Reported) | $11.5B | $12.7B | $11.9B | $7.7B | $10.3B | |
| Operating Income (Adjusted) | $11.5B | $12.7B | $11.9B | $7.7B | $10.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $10.9B | $15.6B | $15.9B | $11.5B | $11.1B | |
| Short Term Investments | $3B | $3.1B | $2.8B | $3.3B | $2.4B | |
| Accounts Receivable, Net | $19.5B | $21B | $24.1B | $31.3B | $28.5B | |
| Inventory | $18.5B | $17.8B | $19.1B | $18B | $18.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.3B | $5.3B | $2.6B | $3.2B | $3.1B | |
| Total Current Assets | $56.4B | $60B | $65.6B | $67.9B | $68.6B | |
| Property Plant And Equipment | $33.3B | $32B | $30.7B | $30.4B | $28.9B | |
| Long-Term Investments | $21.1B | $23.2B | $21.3B | $23.3B | $29.1B | |
| Goodwill | $79.6B | $79.1B | $78.2B | $91.3B | $91.3B | |
| Other Intangibles | $31.1B | $29B | $24.8B | $29.2B | $27.3B | |
| Other Long-Term Assets | $4.6B | $4.7B | $4.6B | $4.7B | $4.8B | |
| Total Assets | $238.5B | $240.5B | $236.1B | $257.7B | $260.8B | |
| Accounts Payable | $34.9B | $38.7B | $44.4B | $49.8B | $55.1B | |
| Accrued Expenses | $14.2B | $17.7B | $18.7B | $23.5B | $20.8B | |
| Current Portion Of Long-Term Debt | $5.4B | $4.2B | $1.8B | $2.8B | $3.6B | |
| Current Portion Of Capital Lease Obligations | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Other Current Liabilities | $5.8B | $5.6B | $2.8B | $1.1B | $1.2B | |
| Total Current Liabilities | $62B | $67.8B | $69.4B | $79.2B | $84.6B | |
| Long-Term Debt | $78B | $70.1B | $67.3B | $74.7B | $75.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $168.8B | $165.1B | $164.4B | $181.1B | $185.1B | |
| Common Stock | $17M | $47.4B | $18M | $18M | $18M | |
| Other Common Equity Adj | $1.4B | $965M | -$1.3B | -$297M | -$120M | |
| Common Equity | $69.4B | $75.1B | $71.5B | $76.5B | $75.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $312M | $306M | $300M | $175M | $170M | |
| Total Equity | $69.7B | $75.4B | $71.8B | $76.6B | $75.7B | |
| Total Liabilities and Equity | $238.5B | $240.5B | $236.1B | $257.7B | $260.8B | |
| Cash and Short Terms | $10.9B | $15.6B | $15.9B | $11.5B | $11.1B | |
| Total Debt | $83.4B | $74.4B | $69.1B | $77.4B | $79.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $12.8B | $20.1B | $16.3B | $9.7B | $11.3B | |
| Short Term Investments | $3B | $2.8B | $3.1B | $2.8B | -- | |
| Accounts Receivable, Net | $22.5B | $23.9B | $30.3B | $29.4B | $33.9B | |
| Inventory | $17.4B | $18.1B | $18B | $17.6B | $19B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.3B | $2.2B | $3.1B | $3.8B | -- | |
| Total Current Assets | $60.8B | $68.3B | $70.1B | $67.3B | $77.1B | |
| Property Plant And Equipment | $33.2B | $30.9B | $30.6B | $29B | $28.1B | |
| Long-Term Investments | $22.6B | $20.8B | $21.9B | $29.1B | $31.8B | |
| Goodwill | $79.1B | $78.1B | $91.3B | $91.3B | -- | |
| Other Intangibles | $29.5B | $25.2B | $29.6B | $27.8B | -- | |
| Other Long-Term Assets | $4.7B | $4.8B | $4.8B | $4.8B | -- | |
| Total Assets | $234.9B | $231.2B | $251.3B | $252.4B | $255.3B | |
| Accounts Payable | $39.5B | $43.4B | $48.9B | $54.9B | $60.9B | |
| Accrued Expenses | $16.1B | $19.4B | $22.6B | $20.2B | -- | |
| Current Portion Of Long-Term Debt | $1.6B | $1.4B | $2.1B | $4.9B | -- | |
| Current Portion Of Capital Lease Obligations | $1.8B | $1.7B | $1.7B | $1.9B | -- | |
| Other Current Liabilities | $5.7B | $6.5B | $6.2B | $2B | -- | |
| Total Current Liabilities | $64.7B | $72.4B | $81.6B | $84.6B | $92.7B | |
| Long-Term Debt | $75.3B | $68B | $76.2B | $75.1B | $74.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $160.3B | $160.2B | $176.8B | $177.3B | $182.2B | |
| Common Stock | $47.1B | $48B | $18M | $18M | $18M | |
| Other Common Equity Adj | $1.1B | -$1.6B | -$1B | $209M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $310M | $328M | $173M | $162M | $182M | |
| Total Equity | $74.6B | $71B | $74.5B | $75.1B | $73.1B | |
| Total Liabilities and Equity | $234.9B | $231.2B | $251.3B | $252.4B | $255.3B | |
| Cash and Short Terms | $12.8B | $20.1B | $16.3B | $9.7B | $11.3B | |
| Total Debt | $76.8B | $69.4B | $78.4B | $80B | $78.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2B | $7.9B | $4.3B | $8.4B | $4.6B | |
| Depreciation & Amoritzation | $4.4B | $4.5B | $4.2B | $4.4B | $4.6B | |
| Stock-Based Compensation | $400M | $484M | $447M | $588M | $540M | |
| Change in Accounts Receivable | -$1.5B | -$2.7B | -$3B | -$6.3B | -$1.3B | |
| Change in Inventories | -$973M | $735M | -$1.4B | $1.2B | -$102M | |
| Cash From Operations | $15.9B | $18.3B | $16.2B | $13.4B | $9.1B | |
| Capital Expenditures | $2.4B | $2.5B | $2.7B | $3B | $2.8B | |
| Cash Acquisitions | $866M | $146M | $1.4B | $16.6B | $95M | |
| Cash From Investing | -$5.5B | -$5.3B | -$5B | -$20.9B | -$7.6B | |
| Dividends Paid (Ex Special Dividend) | $2.6B | $2.6B | $2.9B | $3.1B | $3.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $10B | $987M | -- | $16.1B | $9.8B | |
| Long-Term Debt Repaid | -$15.6B | -$10.3B | -$4.2B | -$8.2B | -$4.8B | |
| Repurchase of Common Stock | -- | -- | $3.5B | $2B | $3B | |
| Other Financing Activities | $337M | -$13M | -$449M | -$382M | -$159M | |
| Cash From Financing | -$8.2B | -$11.4B | -$10.5B | $2.7B | -$1.1B | |
| Beginning Cash (CF) | $7.9B | $12.5B | $13.1B | $8.3B | $8.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.2B | $1.6B | $614M | -$4.8B | $359M | |
| Ending Cash (CF) | $10B | $14.1B | $13.7B | $3.5B | $9B | |
| Levered Free Cash Flow | $13.4B | $15.7B | $13.5B | $10.4B | $6.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.6B | -$3.4B | $2.3B | $71M | -$4B | |
| Depreciation & Amoritzation | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B | |
| Stock-Based Compensation | $114M | $105M | $154M | $133M | $138M | |
| Change in Accounts Receivable | -$1.1B | $678M | -$3.1B | -$3.8B | -$3.4B | |
| Change in Inventories | -$420M | -$884M | -$495M | -$1.6B | -$1.7B | |
| Cash From Operations | $5.5B | $9.1B | $2.7B | -$745M | $796M | |
| Capital Expenditures | $608M | $580M | $545M | $670M | $698M | |
| Cash Acquisitions | $27M | -$9M | $18M | $12M | $290M | |
| Cash From Investing | -$847M | -$805M | -$771M | -$3.3B | -$2.1B | |
| Dividends Paid (Ex Special Dividend) | $659M | $726M | $779M | $837M | $846M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $987M | -- | -$1B | $600M | -- | |
| Long-Term Debt Repaid | -$2.4B | -$2.7B | -$947M | -$1.7B | -- | |
| Repurchase of Common Stock | -- | -- | -$3M | -$1M | -- | |
| Other Financing Activities | $32M | $12M | -$96M | $3M | -- | |
| Cash From Financing | -$2B | -$3.2B | -$2.7B | -$1.6B | -$1.4B | |
| Beginning Cash (CF) | $9.8B | $17.3B | $13.1B | $6.9B | $9.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.7B | $5.1B | -$752M | -$5.7B | -$2.7B | |
| Ending Cash (CF) | $12.5B | $22.4B | $12.4B | $1.3B | $6.5B | |
| Levered Free Cash Flow | $4.9B | $8.5B | $2.2B | -$1.4B | $98M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.6B | $3.3B | $8.7B | $5B | $428M | |
| Depreciation & Amoritzation | $4.5B | $4.3B | $4.3B | $4.6B | $4.6B | |
| Stock-Based Compensation | $458M | $479M | $567M | $530M | $537M | |
| Change in Accounts Receivable | -$1.5B | -$1.2B | -$4.9B | -$3.3B | -$7.9B | |
| Change in Inventories | $79M | -$777M | $285M | $283M | -$1.4B | |
| Cash From Operations | $17.8B | $22.1B | $14.1B | $4.6B | $9.1B | |
| Capital Expenditures | $2.6B | $2.6B | $2.8B | $2.9B | $2.8B | |
| Cash Acquisitions | $173M | $2.1B | $15.8B | $205M | $439M | |
| Cash From Investing | -$5.1B | -$6.4B | -$19.8B | -$8.3B | -$4.4B | |
| Dividends Paid (Ex Special Dividend) | $2.6B | $2.8B | $3.1B | $3.3B | $3.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3B | -- | $15.9B | $5.8B | -- | |
| Long-Term Debt Repaid | -$13B | -$6.6B | -$7.8B | -$2.1B | -- | |
| Repurchase of Common Stock | -- | $2B | $3.5B | $3B | -- | |
| Other Financing Activities | $371M | -$388M | -$378M | -$200M | -- | |
| Cash From Financing | -$12.3B | -$11.2B | $1.5B | -$2.5B | -$2.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $512M | $4.6B | -$4.2B | -$6.2B | $2.2B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $15.2B | $19.5B | $11.3B | $1.7B | $6.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.6B | $2B | $6.3B | $3B | -$1.2B | |
| Depreciation & Amoritzation | $3.4B | $3.2B | $3.2B | $3.5B | $3.5B | |
| Stock-Based Compensation | $346M | $341M | $461M | $403M | $400M | |
| Change in Accounts Receivable | -$3.5B | -$2B | -$3.9B | -$986M | -$7.5B | |
| Change in Inventories | $1.1B | -$415M | $1.3B | $355M | -$982M | |
| Cash From Operations | $14.3B | $18.1B | $16.1B | $7.2B | $7.2B | |
| Capital Expenditures | $1.9B | $2B | $2.1B | $2B | $2B | |
| Cash Acquisitions | $135M | $2.1B | $16.5B | $85M | $429M | |
| Cash From Investing | -$3.8B | -$4.9B | -$19.6B | -$7.1B | -$3.9B | |
| Dividends Paid (Ex Special Dividend) | $2B | $2.2B | $2.4B | $2.5B | $2.6B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $987M | -- | $15.9B | $5.6B | -- | |
| Long-Term Debt Repaid | -$7.8B | -$4.2B | -$7.7B | -$1.7B | -$762M | |
| Repurchase of Common Stock | -- | $2B | $2B | $3B | -- | |
| Other Financing Activities | -$81M | -$456M | -$385M | -$203M | -$170M | |
| Cash From Financing | -$8.5B | -$8.3B | $3.7B | -$1.6B | -$2.9B | |
| Beginning Cash (CF) | $22.5B | $41B | $41.8B | $29.4B | $31.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.9B | $4.9B | $70M | -$1.4B | $468M | |
| Ending Cash (CF) | $24.5B | $45.8B | $41.8B | $28B | $31.6B | |
| Levered Free Cash Flow | $12.3B | $16.1B | $13.9B | $5.2B | $5.2B | |
Get CVS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CVS
Sector
P/E ratio
207.42x
23.88x
PEG ratio
0.07x
-0.01x
P/B ratio
1.38x
1.82x
Price / LTM sales
0.26x
1.59x
Growth Metrics
CVS
Sector
Revenue growth
7.83%
4.73%
Earnings growth
-4633.14%
11.11%
Revenue (5-year growth)
7.75%
6.46%
Earnings forecast
$0.99
-$0.18
Profitability
CVS
Sector
Profitability FY 2024
$51.3B
$3.6M
Return on invested capital
0.27%
-31.77%
Return on assets
0.17%
-28.18%
Return on equity
0.57%
-37.47%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
11
Estimated Next Earnings Date
Jan
28
Balance Sheet
CVS
Sector
Total cash
$11.3B
$26.3M
Short term investments
$2.4B
$26M
Total assets
$260.8B
$76.9M
Long term debt
$78.6B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.78% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 8.96% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
